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INTRODUCTION
The primary goal in raising dairy bull calves is to
attain market weight as efficiently and economically as
possible. Two major steps to reaching that goal are 1) to
increase feed efficiency and therefor profitability and 2) to
maintain healthy animals, thereby decreasing mortality losses.
Several potential methods that may reduce feed to gain costs
are to increase the feed efficiency of the calf or to decrease
days to weaning. Feeding lasalocid has been shown to increase
weight gain in dairy calves (Anderson et al . , 1988).
Lasalocid was also credited with enhancing microbial
development with early weaning. The lasalocid was delivered
in milk, prestarter and starter in that study. It has not
been determined if administration of lasalocid in all three
feeds was the most effective route for delivery of that
treatment. The purpose of the first study presented here is
to determine the most effective route for the administration
of lasalocid to young bull calves.
The use of antibiotics in feeds to maintain health is
becoming increasingly unpopular with consumers. The use of
vitamins 1 natural abilities to promote animal health is a
potential area for further investigation. Reddy et al. (1987)
have demonstrated the value of vitamin E in enhancing the
immune response of dairy calves. The use of vitamin C to
enhance immune responses has been shown for other species and
suggested for cattle. A cooperative relationship has been
established for vitamins C and E (Bendich, 1987) . The value
of vitamin C alone and vitamins C and E together for changing
various immune functions of the young calf has yet to be
established and is the second purpose of this study.
REVIEW OF THE LITERATURE
Lasalocid Effects on Rumen Development
and Growth of the Young Calf
Rumen and Metabolic Development of the Young Calf
The young calf begins life essentially as a monogastric
animal. As the calf ages and grows a digestive and metabolic
transition occurs, resulting in the ruminant animal (Huber,
1969) . The rumen of the newborn calf is relatively small
compared to the other stomach compartments. When the calf is
bottle- or nipple pail- fed, the esophageal groove is
eriectively closed and diverts the liquid past the rumen into
the abomassum. However, when fed via an open bucket, milk
frequently enters the rumen (Tamate, 1962, Otterby and Linn,
1981)
.
Rumen development is influenced by diet (Tamate, 1962)
.
Extensive papillary development was seen with hay and grain
diets compared to all-milk diets. Papillary development and
absorptive capacity have been related to increased metabolic
activity of the rumen epithelial tissue (Huber, 1969, Sutton,
1963a, b) . Young et al. (1965) have shown that young milk-fed
calves have the metabolic capacity to utilize rumen
fermentation end products and that these products (volatile
fatty acids) can be absorbed from the small intestine. For
example, increased intraruminal acetate, via infusion,
increased blood levels of acetate, /?-hydroxybutyrate, lactate
and malate. Infusion of propionate increased propionate,
acetate and lactate concentrations and decreased
concentrations of formate and glycolate, while the infusion
of butyrate caused increased concentrations of butyrate,
acetate, /3-hydroxybutyrate, lactate and malate.
Blood glucose decreases with age through 8 weeks of age,
at which time it stabilizes (Otterby and Linn, 1981) . Johnson
et al. (1982) studied the changes in plasma glucose and
insulin concentrations associated with propionate in
preruminant calves fed an all-milk replacer diet. Increased
propionate or glucose caused a strong insulin response. The
increases seen in propionate-fed calves was independent of the
early post-feeding plasma glucose increase. When infused with
propionate, the calves' plasma insulin concentration increased
and plasma glucose concentration declined. The calves that
had been supplemented with glucose or propionate were less
sensitive to the propriontate infusion than were the control
animals. The development of rumen flora and fauna of young
calves with respect to diet was studied by Lengemann and Allen
(1959) and Anderson et al. (1987a, b). When given the
opportunity, some young calves would consume solid feed
earlier than two weeks of age, but three weeks were required
to produce a flora as diverse as an adult following dry feed
consumption. Calves reared solely on milk had very high
counts of aerobic bacteria in the rumen. Lengemann and Allen
(1959) found established protozoa populations in the rumen by
one week of age and near adult levels by five weeks of age.
The benefits of early weaning of calves accrue both to
the calf and to the producer (Agabawi et al., 1968; Morrill,
1984; Morrill et al., 1984, Quigley et al., 1985; Anderson et
al., 1987 a,b, Jorgenson et al . , 1970, Owen and Larson, 1982).
Benefits for the producer include reduction in labor and feed
costs. Conversely, some researchers have found no benefit or
negative results for the calf due to early weaning. (DePeters
et al., 1986) . This discrepancy is due in part to the variety
of dry feeds used as well as the age of weaning of the calf.
Morrill (1984) advocated the use of a highly digestible
prestarter that is introduced to the calf at day four of age.
This feeding regime was used by Anderson (1988) . Calves were
easily weaned by four weeks of age and some as early as two
weeks. Anderson et al., (1987a) found an increase of ruminal
VFA concentrations associated with the increased dry feed
consumption of this early weaning program. The low ruminal
pH resulting from early weaning and increased dry feed
consumption delayed protozoa establishment in the rumen
(Anderson et al., 1987b) and may inhibit cellulolytic activity
(Slyter, 1986)
.
Anderson et al.(1987) looked at the changes in rumen
microbes and their end products with respect to early or
conventional weaning, i.e. four weeks and six weeks of age
respectively. Total lactate was higher for early weaned
calves. Early weaned calves also exhibited higher total VFA
concentrations. At five weeks of age facultative counts were
higher and lactobacillus counts tended to be higher in the
early weaned calves. This group also had higher counts of
amylolytic bacteria at six weeks and higher counts of lactate-
utilizing bacteria at five weeks of age. The proportion of
amylolytic bacteria increased with age, proteolytic bacteria
increased at ten weeks of age and lactate utilizing bacteria
decreased, beginning at week five. Ruminal NH3-N decreased
with age. The early weaned calves had a higher number of
methanogens between five and eight weeks of age. The authors
concluded that the earlier dry feed was consumed by the calf,
the earlier microbial development occurred, resulting in
greater ruminal metabolic activity.
Young et al. (1965) described the rumen of the newborn
as being nonfunctional for the newborn ruminant, however the
VFAs produced in the rumen could be utilized as early as
three weeks of age. In the young milk-fed calf, acetate,
propionate and butyrate were metabolized by established
pathways. Acetate and butyrate caused increased ketone
production and propionate decreased its production.
Propionate and butyrate were egual to each other but greater
than acetate in contributions to glucose carbon. Young et al.
(1965) infused acetate, butyrate and propionate into calf
rumen, and each infusion resulted in decreased blood glucose
concentration and increased blood lactate concentration. The
concentration and specific activity of malate increased with
the infusion of acetate and butyrate. This suggests activity
of a portion of the glyoxylate pathway.
Biochemistry of Lasalocid
Lasalocid (X-537, RO 2-2985) is a carboxylic polyether
ionophore, produced by Streptomyces sp. It forms an
electrically neutral zwitterionic complex with cations,
promoting an electrically neutral exchange diffusion of
cations (Pressman and Fahim, 1982) . Lasalocid tends to
dimerize, forming electrically neutral complexes with
2+ 2+important ions such as Ca and Mg (Pressman and Fahim,
1982) . Other divalent cations which lasalocid binds are Ba +
,
Cu2+ , Fe2+ , Ni2+ , and Zn2+ . Elasser (1984) cites areas of
mineral metabolism that may result in altered mineral balance
due to ionophores; 1) ion presence and bioavailability
(Ammerman and Miller, 1972, Miller, 1975), 2) ion uptake and
transport across biological membranes, 3) whole body
distribution and storage, 4) interactions between the ions, and
5) homeostatic mechanisms regulating uptake and excretion.
The results of ionophore-mediated changes in metabolism may
result in the compromised function of tissues dependent upon
appropriate release and acguisition of ions.
The exchange-diffusion transport system of carboxylic
ionophores is not as disruptive to biological membranes as are
the neutral ionophores. Lasalocid has a wide range of
affinities and transport capabilities, including inorganic
polyvalent and alkali ions as well as primary amines such as
catecholamines. The relative affinity for lasalocid is K >
Rb+ > Na + > Cs + > Li + . Lasalocid also increases the
permeability of membranes to H+ ions (Henderson et al . , 1969;
Green, 1975) . Lasalocid affects transport of ions across
membranes by forming soluble complexes with the hydrated form
of the metal ion. It can also affect transmembrane movement
of an ion that it does not chemically react with or bind to
directly (Elasser, 1984)
.
Physiological Properties of Lasalocid
Carboxylic polyether ionophore antibiotics were
originally used as anticoccidial feed additives for poultry.
They are utilized in ruminant nutrition to increase ruminal
propionic acid, depress methanogenesis, and depress rapid
ruminal proteolysis and deamination of dietary proteins
(Bergen and Bates, 1984) . When these ionophores are fed with
readily fermentable carbohydrates, they depress feed intake
without affecting weight gains, creating improved feed
conversion ratios (Zinn,1987). When ionophores are fed with
diets containing a greater concentration of roughages, the
effect of ionophores is to maintain feed intake and to
increase body weight gain, resulting in improved feed
conversion ratios.
Three areas of metabolism that contribute to the improved
feed conversion reported by Bergen and Bates (1984) were: 1)
increased efficiency of energy metabolism, 2) improved
nitrogen metabolism, and 3) reduction of disorders in feedlot
cattle. Dinius (1976) suggested the improved feed efficiency
was due to selective alterations of rumen microflora, favoring
propionate producing microorganisms, thus reducing the
acetate/propionate ratio. Thornton (1976) has shown that
ionophores decrease ruminal methane production as well. The
mechanism for this selective process is believed to be the
transport of ions into susceptible species leading to a
disruption of the microbes normal physiology (Wolin, 1981)
.
Lasalocid effects on mineral status of the body have been
investigated by several researchers. The duodenal mucosal
mineral concentrations were reduced when lasalocid was fed in
the diet or acutely infused (Linder and Munro, 1977) . Mucosa
from lasalocid-treated animals contained more copper than a
control group while the copper concentrations in the livers
did not differ. The iron content of mucosal tissues was
higher in lasalocid-fed calves compared to controls. Van
Ryssen and Barrowman (1987) observed no difference in liver
copper concentration for lasalocid-fed sheep compared to
controls when given copper in the diet. Beef cows fed
lasalocid while grazing oat pastures did not have different
Mg, K, or Zn concentrations from controls. An increase of Ca
concentrations and a decrease of Na concentrations was
observed four months after initiation of lasalocid
supplementation in the treated cows. After two months of
supplementation with lasalocid, acetate and butyrate molar
proportions decreased in those cows, which led to a decreased
acetate/propionate ratio. Spears and Harvey (1982) observed
decreased magnesium concentrations in steers on pasture which
were fed 200-300 mg/day lasalocid. In a continuous culture
experiment, lasalocid decreased the acetate to propionate
ratio, and a magnesium by lasalocid interaction existed for
butyrate. A lasalocid by potassium interaction was observed
for propionate and butyrate. Plasma glucose was higher for
steers fed the high doses of lasalocid. Chirase et al. (1988)
concluded from their data that the efficacy of lasalocid
altering VFA concentrations of ruminal fermentation might be
enhanced by optimizing other nutrients. Armstong and Spears
(1988) studied the effect of administering lasalocid
intravenously and the resulting effects on various blood
metabolites. Blood insulin, glucose, free fatty acid, Mg, P,
and K concentrations were not affected by lasalocid
injection. Neither growth hormone or luteinizing hormone were
affected by the lasalocid administration.
Starnes et al., (1984) studied the influence of lasalocid
on mineral metabolism and ruminal urease activity in steers.
Ca, Mg, P, K, Na, Zi and Cu serum and rumen values were
measured. Apparent absorption of Na, Mg, and P were increased
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by lasalocid intake. Only Zi and Cu concentrations were
significantly increased from the control group. K and Ca
absorption were not affected by lasalocid administration,
however concentrations of soluble K and Ca in rumen fluid were
lower than those of controls. Bacterial urease was decreased
by 28% in steers fed lasalocid.
Volatile fatty acids have been shown to increase plasma
insulin concentration in cattle and sheep (Johnson et al.,
1982) , as well as in pre-ruminant milk-fed lambs. Johnson
et al., (1982) investigated whether preruminant calves were
stimulated to secrete insulin with propionate or glucose
feeding and propionate infusion. All calves exhibited a
plasma insulin rise and plasma glucose decline with propionate
infusions. The calves fed glucose and propionate appeared
less sensitive to the infusions than the control calves.
Steers fed 220 or 330 ppm lasalocid had less complete
crude protein digestion in the large intestines than did
control animals. Lasalocid lowered ruminal phosphorus
digestion. Apparent digestibility of Ca, P, Mg, and K in the
small intestine was higher for steers fed lasalocid than for
those fed control diets. Apparent total digestibility for Ca
and Mg were higher for lasalocid-fed animals as well (Gado et
al. , 1986)
.
Inhibition of lactate producing microorganisms has been
attributed to lasalocid (Dennis et al . , 1981) . Both lasalocid
and monensin were efficient in preventing lactic acidosis when
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cattle were engorged with grain or a glucose solution
(Nagaraja et al., 1981, 1982). Lactate producers with
succinate as a major end product, and none of the lactate
fermenters , were inhibited by lasalocid (Dennis et al., 1981)
.
Lasalocid added in vitro to rumen samples reduced protozoa
numbers (Dennis et al., 1986); however, young calves do not
have a substantial protozoa population until after six weeks
of age (Anderson et al., 1987). Anderson et al . (1988)
studied the influence of lasalocid-feeding on growth and
ruminal flora of early weaned calves age four days to 12
weeks. Treatments were a control group and a lasalocid-fed
group. The lasalocid-fed group was fed lasalocid in milk,
pre-starter and starter to deliver approximately one mg/kg
body weight. Calves fed lasalocid had greater intake after
six weeks of age, at which time the lasalocid intake averaged
1.5 mg/kg body weight. Weight gains were higher for the group
receiving lasalocid at week 5, 8, 10 and 12. Fecal scores
were not different between treatments. The ruminal pH of the
lasalocid-fed group was higher at one and two weeks and tended
to be lower than the control group at four weeks of age.
Rumen NH3-N concentrations decreased with the age of the
calf. The lasalocid-fed calves reached higher total VFA
concentrations at weeks 5,6, and 10. Lasalocid-fed calves had
a lower acetate/propionate ratio. Amylolytic bacteria had a
treatment by age interaction. Lasalocid supplementation
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seemed to depress ruminal bacterial fermentation of milk and
dry feed during the first two weeks. This study did not
differentiate from which source, milk, prestarter, or starter,
the lasalocid was effective.
Neuendorf f et al. (1985) found lasalocid did not affect
height, weight: height ratio, length, or heart girth of Brahman
bulls during puberal development. The lasalocid fed bulls had
higher propionate and lower acetate and butyrate of ruminal
VFA, with no change in total VFA. Lasalocid-fed bulls tended
to have a greater average daily gain and had greater feed
conversion, while heifers supplemented with monensin reached
puberty at a younger age than control animals but weighed less
than the control calves (McCartor et al., 1979, Moseley et
al., 1977). Feeding lasalocid to cows while on pasture did
not affect calf gain or 205-day adjusted weaning weight (Hopman
and Weber, 1986)
.
Benz et al. (1987) , using chicks and rats, determined the
effects of two ionophores, monensin and lasalocid, on internal
organ mass. Chicks' liver weights did not differ with the
level of ionophore intake. The heart weight of chicks
differed due to ionophore consumption. Liver weight and
relative liver weight both differed with ionophore consumption
for rats. These data indicated that ionophores alter vital
organ mass and may alter organ function.
13
Toxicity
Lasalocid is considerably less toxic than monensin
(Galitzer, 1986a, b) when delivered orally to cattle. Lasalocid
administered intravenously to steers did not alter
metabolites, mineral concentrations, or behaviors (Armstong
and Spears, 1988) compared to controls, while monensin did
alter all of those parameters. Galitzer et al. (1982) found
that concentrations of 25-75 mg/kg body weight were toxic but
not lethal. Lasalocid delivered at 100 to 125 mg/kg caused
death to the steers at day 6 and 10 respectively. These
dosages are 100 and 125 times the therapeutic doses.
Administration of 1 and 10 mg/kg of lasalocid caused no toxic
signs (Galitzer et al., 1986 a,b) . Altered values of blood
leukocytes, erythrocytes, hemoglobin hematocrit, total
protein, albumin, creatinine, urea nitrogen, total bilirubin,
creatine kinase, lactic dehydrogenase, calcium, chloride,
inorganic phosphate, urine pH and specific gravity all changed
one day after oral lasalocid administration.
The initial use of lasalocid with cattle was as a
coccidiostat. Lasalocid has been shown effective in
preventing coccidial infections from E_;_ zuernii and E±_ bovis
in ten to twelve week old calves and in preventing ovine
coccidia (Stromberg et al., 1982; Foreyt, 1986; Foreyt et al . ,
1986; Foreyt, 1981) . However, when lasalocid fed calves were
challenged with Sarcocystis bovicanis, they were not protected
from sarcocystosis (Foreyt, 1986) . A recommendation of
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Bergstrom and Etherton (1984) recommended performing routine
fecal analysis rather than treating routinely.
Ascorbic Acid and the Immune System of Ruminants
Ascorbic acid (vitamin C) is a water soluble vitamin that
is well known for the prevention of scurvy. The physiological
role of vitamin C at levels above those reguired to prevent
clinical signs of scurvy is essential to the general health
of the organism. Vitamin C also plays an interactive role
with other essential vitamins and minerals. How vitamin
deficiencies and supplements beyond recommended daily
allowances affect the organism's ability to mount immune
reactions when the animal is compromised by stress or disease
is currently under investigation by some researchers, and is
the purpose of this study.
Physical Properties
Ascorbic acid is a carbohydrate that appears as a white
crystalline compound. It has a molecular weight of 176.1 and
a melting point of 190 to 192 °C (Bauernfeind, 1982) . It is
readily soluble in water, but is irreversibly oxidized in
solution. Ascorbic acid is relatively stable in air.
15
Metabolism
Ascorbic acid absorption is believed to be a passive
process occurring primarily in the ileum in animals that
synthesize it. In ruminants, absorption efficiency is low due
to ascorbic acid destruction by microbial action and other
unknown factors (Hornig et al. , 1984, Itze, 1984). Therefore,
the amount of ascorbic acid a ruminant can reap from a feed
depends on rumen bypass of the vitamin.
Ascorbic acid can be synthesized from glucose in many
species. Therefore, it is not considered an essential dietary
nutrient for most domestic animals, although it is
physiologically essential for all of them. The rate of
ascorbic acid synthesis varies between species and from animal
to animal (Chatterjee, 1973) . Of the farm animals, the pig
has the lowest rate, 8.1 mg/kg/d. The highest rate is that
of the goat which synthesizes 32.6-190.0 mg/kg/d. Cattle
synthesize ascorbic acid at 15.7-18.3 mg/kg/d and the
synthesis rate for sheep is 24.8 mg/kg/d (Levine, 1986). The
chicken and rat, like cattle, have the ability to synthesize
ascorbic acid. The chick synthesizes it in the kidney and the
rat and cattle in the liver (Hornig, 1984) . The synthesis rate
of ascorbic acid has been determined to be controlled by the
amount of free glucose available to the animal. Problems
encountered in determining ascorbic acid needs' include the 10-
16
fold difference between the ascorbic acid needed to maintain
general health and the amount needed to prevent scurvy
(Levine, 1986) . Whether the rate of synthesis needed to
maintain health is sufficient for the animal during stress is
not yet completely or unquestionably determined.
During periods of stress, such as starvation, drug
treatment, or environmental stress, the rat has an adaptive
increase in the activity of enzymes involved in the
biosynthesis of ascorbic acid, resulting in greater
availability of ascorbic acid. It is not known whether this
is true for other species as well. The chick and calf both
experience a lag phase in the production of ascorbic acid
between birth and when ascorbic acid synthesis is at adult
levels of production (Hornig, 1984, Bouda et al., 1980).
Current evidence suggests that at this age these animals are
not ready to have the biosynthetic capacity for ascorbic acid
synthesis increased by stress conditions. Consequently, the
level of synthesis is not sufficient to compensate for
increased ascorbic acid requirements during stress. During
stress, supplemental ascorbic acid has been beneficial to the
chicken affecting growth rate, egg production, egg shell
strength and thickness, fertility and spermatozoan production,
counteracting unfavorable environmental conditions, and cases
of intoxication or disease. The relationship of stress and
17
ascorbate will be discussed in greater detail later.
Ascorbic acid metabolism in farm animals has been
investigated for swine, ruminants and poultry. When ascorbic
acid was supplemented to growing pigs, results indicated
nearly an egual number of negative or eguivocal reports as
positive reports (Brown, 1984) . The effect of stress on the
concentration of ascorbic acid in the neonate was
investigated by Brown (1984) and Dvorak (1984). A 14:1
ascorbic acid gradient existed across the placenta in swine.
When the piglet was born a marked decrease of ascorbic acid
concentration in all but the liver tissue was seen (Brown,
1984) . At the same time, ascorbic acid concentrations in the
liver increased over fetal concentrations. Dvorak (1984)
reported that blood serum ascorbic acid concentration of
piglets was highest one day after birth and then declined
rapidly until it became constant between 20 days and 10 weeks.
No differences were seen in ascorbic acid concentration with
weaning. The urinary ascorbic acid content was several times
higher than in serum. Ascorbic acid excretion rose with
colostrum ingestion and was significantly lower for fattening
pigs and for sows.
Researchers have studied the tissue distribution of
ascorbic acid for fish, chickens, rat, mice, man and guinea
pigs. Labeled (1- 14C) ascorbic acid has been used to
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investigate retention capacity for ascorbic acid in guinea
pigs, fish and rats. Guinea pigs highest retention was in the
central nervous system, pituitary and adrenal glands, salivary
glands, spleen, testes, eye lens, and bone marrow, implying
a distinct role in those tissues for ascorbic acid (Hornig,
1984) . The fish showed accumulation in the collagenic skin
area, liver, renal and anterior kidney, bones and the eggshell
membrane. The area of highest accumulation in the chicken was
the liver: 10 % after intravenous injection and 5% following
oral dosing. Spleen, lungs and kidneys each contained about
1% after either route of application. This suggests that the
kidney is only the location for biosynthesis of ascorbate and
that formed ascorbate passes guickly out of the kidney into
other tissues (Caudwell, 1977, Hornig and Frigg, 1979). The
highest concentrations of ascorbic acid in tissue of the chick
and fish are in the liver. The white muscle ascorbic acid
concentration of the chicken was not affected by differences
of dietary concentrations of ascorbic acid. Rat ascorbic acid
concentrations increase in glucocorticoid treated animals
after injection of sodium barbital or feeding supplements
containing chromium or tungsten. How much of these findings
are applicable to farm animals is not known.
19
Physiological Role
The reactions for which ascorbic acid is needed are
diverse. The ascorbic free radical can serve as a reducing
or as an oxidizing agent (Bendich et al., 1987). The role of
ascorbic acid may be to transfer electrons to enzymes that
provide reducing eguivalents in hydroxylation, amidation, or
other reactions (Levine, 1986) . Ascorbate is capable of
reducing Cu2+ , Fe3+ , and reducing oxygen to water. Ascorbic
acid acts in hydrolase enzyme reactions as a cofactor
involving two substrates. It is also involved as a
physiological reducing agent in the prolyl and lysyl
hydroxylase system in collagen formation (Hornig et al., 1984,
Levine, 1986) . Ascorbic acid has a role in carnitine
biosynthesis (Hughes, 1981) . Carnitine is important in the
transport of fatty acids into mitochondria, providing energy
for the cells in retained contractions, and has two sources;
1) the diet or 2) endogenous synthesis from dietary lysine and
methionine. The hydroxylation of 4-hydroxyphenyl pyruvic
acid reguires ascorbic acid to form homogentisic acid in
tyrosine metabolism. The 21 hydroxylation system of
corticosteroid synthesis is inhibited by ascorbate. Ascorbic
acid promotes non-heme iron absorption from food, most
effectively when ingested with the food or feed. The effect
of ascorbic acid on iron absorption is dose dependent,
20
increasing absorption up to seven fold. Ascorbic acid has
been shown to have a protective effect against toxicity of the
heavy metals cadmium, nickel, lead and vanadium in quail and
rats when the metals are ingested together with ascorbic acid
(Suzuki and Yoshida, 1979; Fox, 1975). Ascorbate also reduced
the toxic hexavalent chromium to the trivalent form which is
not known to cause major adverse effects (Samitz et al.,
19 68) . Inversely, ascorbate has been demonstrated to impair
copper uptake and utilization (Van Campen and Gross, 1968,
Disilvestro and Harris, 1981) . The role of ascorbate in
enhancing calcium uptake in the intestines and in the
maintenance of egg shell quality has been demonstrated (Pardue
and Thaxton, 1986, Thornton and Moreng, 1959) . However, the
total function of vitamin C in the biochemistry of calcium has
yet to be established.
Ascorbic acid has been shown to be beneficial in
fertility, especially for males. Ascorbate concentration is
greater in Fresian bull semen versus buffalo bull semen. The
bull sperm motility increased over that of the buffalo
corresponding to the ascorbate concentration increase. Adding
ascorbate to collected bull semen influenced the sex of
offspring. The percentage of female offspring of semen with
added ascorbate was increased compared to controls, 55.8
versus 51.3%, respectively. There is some evidence in humans
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that anovulatory women were induced to ovulate with ascorbic
acid supplementation (Hornig et al., 1984).
Stress effects on ascorbic acid concentration in adrenal
glands is pronounced enough to be used as an indicator for
stress measurement (Warris, 1984, Dvorak, 1984). The
administration of ACTH and exposure to cold for 12 hours in
piglets increased the excretion of ascorbic acid, suggesting
some ascorbic acid depletion. Studies with chicks, using heat
and ACTH as stressors, showed ascorbic acid could reduce the
catatoxic effects of stress. The mechanism is thought to be
a reduction in corticosterone production by ascorbic acid.
The synthesis of catecholamines reguires ascorbic acid and the
catecholamines are important to the stress responses of
chickens (Thaxton and Pardue, 1984) . Studies with calves have
shown a reduction in plasma ascorbic acid concentration caused
by lung or gastrointestinal tract infections (Kolb, 1984).
Similarly, reductions in plasma ascorbic acid concentration
have been observed in lambs after infection with Salmonella
typhimurium or S. abortus bovis . Vaccination in cattle also
caused an immediate decrease in plasma ascorbic acid
concentration. When ascorbate was added with a Salmonella
vaccine in pigs and rabbits, immunity development was
improved. Reduced plasma ascorbic acid concentrations have
22
been reported under the influence of parasitosis (Kolb, 1984)
.
Several immunological functions have been investigated
for ascorbic acid. Studies of animals and man suggest that
ascorbic acid may have a direct inhibitory effect on
carcinogenic N-nitrosamine formation. Vitamin C has been
studied in regard to two immune parameters, namely antiviral
and antibacterial effects (Briggs, 1984). This will be
covered in greater detail in a subsequent section.
Ascorbate Metabolism in Ruminants
The highest blood concentration of ascorbic acid in
cattle is found immediately after birth and thereafter the
ascorbic acid concentration in blood slowly declines (Bouda
et al., 1980, Weggert and Moustgaard, 1982). Ascorbic acid
concentrations in newborns vary widely, but are reported at
1030 ug/dl (Bouda et al., 1980) . Studies of monozygotic twins
have shown strong uniformity in plasma ascorbic acid
concentration between the twins. This points to a possible
genetic influence of ascorbic acid synthesis and requirement.
This aspect, together with the congenital liver store
variations, are possible explanations of the extreme
variability seen in young calves. Consequently, values of
plasma ascorbic acid concentrations have been reported from
0.2 mg % to 0.8 mg % (Palludan and Wegger, 1984) . Conflicting
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data are reported regarding correlations of plasma ascorbic
acid concentration and seasons (Itze, 1984) . Low blood
ascorbate concentrations, even in ascorbate-synthesizing
animals, can be caused by metabolic disorders, improper
nutrition, inadequate vitamin A or /3-carotene intake and
infectious diseases (Itze, 1984) . The ascorbate content of
liver increases late in fetal life and decreases postnatally.
Since the ascorbic acid content of colostrum and milk is
relatively low and ascorbate synthesis in the liver is not
fully developed in young calves, the requirement for this
vitamin must be covered by the calve' s congenital reserves
(Palludan and Wegger, 1984) . Lundquist and Phillips (1942)
have established that vitamin C synthesis begins 2 to 3 weeks
after birth. The serum ascorbate content of calves depends
on the nutrition of the dams as well as the age and health of
the calves. During gastrointestinal disorders, serum
ascorbate decreases due to decreased milk intake, impaired
resorption and higher utilization of ascorbic acid in diseased
calves. In an experiment designed to investigate ascorbic
acid content of serum in cows and their calves, Itze (1984)
found the lowest serum ascorbic acid concentration in cows and
in their calves was in February and the highest was in April.
Reported calf serum concentrations were quite variable and
values were 67.2 mg/1 at day 1 after birth, dropping radically
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to around 16 mg/1 at day two. A general decrease was observed
throughout the following eight days. Ascorbic acid intake for
calves has been recommended to be 200-250 mg/day (Itze, 1984)
;
however, these recommendations did not allow for the numerous
stressors placed on young calves which are placed in a
calfhouse environment. In the Itze study (1984), serum
ascorbate concentration was high between days 7 and 14 and
dropped drastically at day 14, suggesting an increasing
degradation of ascorbate in the developing proventriculi,
thereby decreasing absorption from the gastrointestinal tract.
Interactions with other Vitamins and Minerals
Both positive and negative interactions occur between
ascorbic acid and other vitamins and minerals. The vitamins
and minerals that are affected by ascorbic acid are vitamins
A and E, iron, copper and selenium. Interactions between
those vitamins and minerals also occur.
Bouda et al. (1980) showed the importance of colostrum
in establishing neonate concentrations of vitamin E, whereas
ascorbic acid concentration was dependent upon fetal levels.
A common property of ascorbic acid and vitamin E is a rapid
reaction with organic free radicals. As early as 1968 the
synergistic relationship of vitamins C and E was proposed
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(Tappel, 1968). Packer et al. (1979), using pulse radiolysis,
directly observed a free radical interaction between ascorbate
and vitamin E. In vitro synergism of these two vitamins was
shown in rat and guinea pig livers. The depleting effect of
weaning on vitamins C and E and the ability to increase
vitamins C and E by dietary means have been demonstrated for
each of the vitamins for weanling pigs (Yen, 1984) . Plasma
values of vitamins C and E each increase with supplementation
of the other vitamin in the rat and in the guinea pig a
sparing effect by ascorbic acid on vitamin E during vitamin
E deficiency has been seen. Vitamin E deficient chicks fed
ascorbic acid had reduced dietary selenium requirements.
Increased intestinal absorption of selenium (Se) but not
vitamin E resulted with dietary ascorbic acid supplementation
in the chick. Dietary Se or vitamin E treatment did not have
an effect on plasma ascorbic acid concentrations, but
mortality was reduced. Bendich et al. (1984) investigated
vitamin C and E interaction and the immune response. Guinea
pigs fed high concentration of vitamin C had increased plasma
vitamin E and increased vitamin E concentration in the lungs.
A synergistic relationship for vitamin C and A has also
been suggested (Itze, 1984) . High levels of vitamin C
supplementation in neonate calves resulted in increased serum
vitamin A concentration. Conversely, pigs showed no effect
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of ascorbic acid in liver or adrenal with different hepatic
vitamin A stores (Dvorak, 1984)
.
There are two areas of importance in the ascorbic
acid and iron (Fe) interaction; intestinal absorption and
postabsorption metabolism at the tissue level. Ascorbic acid
has been shown to increase the intestinal absorption of non-
heme iron in rats and pigs. This is in part due to the
chelating potential of ascorbic acid. Ascorbate is required
for the release of Fe from the ferri-transferrin complex and
its incorporation in hemoglobin (Yen, 1984) . The ascorbic
acid, iron and copper (Cu) interrelationship appears to be
similar in all species. Ascorbic acid decreases serum and
liver copper concentrations in guinea pigs, rats, and other
monogastric species. Ascorbic acid increases serum and
hepatic Fe concentrations, hepatic microsomal cytochrome P-
450 and cytochrome P5 erythrocyte count, hemoglobin, and
hematocrit in guinea pigs (Milne and Omaye, 1980) . In humans,
plasma Cu++ concentration increases during infection,
contrasted to the decrease of iron. This elevation of Cu
has a bacteriostatic effect.
Immunity
Ascorbic acid has been linked to improved protection from
disease. In humans, this concept has been pursued most
27
notably by Linus Pauling (Briggs, 1984) . The effects of
various vitamins on immune responses has just begun to be
investigated for farm animals in the last decade. Ascorbic
acid has been shown to increase cellular immune response, both
in vitro and in vivo, and to affect humoral immunity.
In vitro bacterial phagocytosis by macrophages has been
enhanced with ascorbic acid. This is thought to occur via
enhanced activity of the hexose monophosphate shunt (HMPS)
.
During ascorbic acid deficiency macrophage mobilization and
aggregation are decreased (Sherman, 1986)
.
Likewise, human neutrophil migration toward
leucoattractants can be stimulated by ascorbate, both in vivo
and in vitro (Hornig et al., 1984, Anderson, 1981;1982;
Anderson and Jones, 1982) . Conflicting reports regarding
neutrophil phagocytosis in vitro have been reported (Anderson,
1981) . Again, increased motility has been related to enhanced
activity of the HMPS. However, it has also been linked to
increased intracellular guanosine 5 -monophosphate (GMP) , to
the inhibition of the polymorphonuclear leukocyte
myeloperoxidase/hydrogen peroxide/halide (MPO/H202/halide)
system, or to a serum dependent event. Ascorbic acid has also
been implicated in the immunomodulation of cyclic nucleotide
B and T cells (Panush et al., 1982). Human T and B cells
incubated with ascorbate had increased cyclic GMP and reduced
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cAMP/cGMP, suggesting disturbances of cellular cyclic
nucleotide levels. Other evidence points to changes in
histamine and prostaglandin levels in response to plasma
ascorbic acid concentration (Hornig et al., 1984). The
mechanism of enhancement of the cellular immune response is
yet unknown (Hornig et al., 1984). The transformation
response of lymphocytes bathed in ascorbic acid in response
to concanavalin A (Con A) and phytohemagglutinin (PHA) are
contradictory (Anderson, 1981) . Lymphocytes incubated with
influenza virus were inhibited in PHA-induced transformation
until ascorbate was added and counteracted the inhibition.
In mice and in humans pokeweed mitogen- (PWM) , PHA- and Con A-
stimulation increased lymphocyte blastogenesis with ascorbic
acid supplementation. Both human and mouse ascorbate-
supplemented subjects had lymphocytes that increased
interferon production when challenged with virus. Human
lymphocytes treated with ascorbate produced the lymphokine
leucocyte migration inhibitory factor when cultured with PHA.
The results regarding lymphocyte motility are conflicting.
The infectivity titer of respiratory syncytial virus incubated
with ascorbic acid was reduced at 24 hours and inactivated at
48 hours (White et al., 1986) . Pigs with a hereditary vitamin
C deficiency had decreasing lymphocyte blastogenic responses
to Con A and PHA coincident with decreasing ascorbic acid
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concentrations. When resupplemented with ascorbic acid, the
Con-A stimulated blastogenic response gradually approached the
initial values (Kristensen et al., 1986).
When lymphocytes of guinea pigs supplemented with
vitamins C and E were stimulated with Con A, PHA and LPS, no
effect of vitamin C alone was observed. However there was
some interaction of vitamin C and E. A sparing effect of
vitamin E by vitamin C was shown (Bendich et al., 1984).
Under similar experimental conditions with the addition of
100% oxygen, the guinea pigs fed the high levels of both
vitamins had the highest overall responses (Bendich, 1987)
.
Chicks deficient in water soluble vitamins have been
shown to have a greater % decrease in thymus, bursa, and
spleen weight compared to the total % decrease in body weight.
This is consistent with previous findings of impairment of
cell mediated immune response in water soluble vitamin-
deficient chicks (Ghoshal and Bhattacharyya, 1985)
.
Various effects of ascorbic acid on neutrophils have been
reported. A 5 mM to 25 mM ascorbic acid concentration caused
chemiluminescence of neutrophils. Antimicrobial activity to
E. coli and S . aureus was not affected by ascorbic acid
supplementation in vitro or in vivo dietary supplementation.
Antimicrobial activity was stimulated with intravenous
ascorbic acid administration. Persons with diseases caused
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by abnormal neutrophil motility have been helped with ascorbic
acid supplementation (Anderson, 1981)
•
Ascorbic acid has also been found to inhibit human
natural killer cells (NK cells) in a dose dependent manner.
Vitamin C did not influence effector/target binding or
interferon (IFN) or IL-2 induced increase of NK activity.
When cells were incubated at 4°C for 1 hour and washed, NK
activity was not affected. However, when they were incubated
at 37 °C for 1 hour and washed, NK activity was strongly
suppressed, indicating that vitamin C had to be taken up by
the cells to become inhibitory or that it influences the
cellular metabolism (Hwuyler et all, 1985) . Siegel and Morton
(1984) found increased prostaglandin E2 synthesis by bone
marrow macrophage in mice supplemented with ascorbic acid.
Previous reports had shown increased response to IFN with mice
supplemented with ascorbic acid. However, with mice as with
humans, NK activity decreased with ascorbic acid
supplementation (Siegel and Morton, 1984)
.
The effect of ascorbic acid on the humoral response is
a complex area since it involves elements of the cell mediated
immune response already discussed. Ascorbic acid
supplementation in humans, guinea pigs and catfish has
increased antibody production. In the study with guinea pigs,
a much higher and earlier peak antibody (Ab) titer was
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observed with ascorbic acid supplementation for the primary
Ab response. The secondary responses showed no differences
between treatments. This suggests that ascorbic acid
stimulates an increased IgM response (Prinz et al., 1980).
IgA and IgM as well as the complement component C3 were
increased with ascorbic acid supplementation in humans (Prinz
et al., 1977). Ascorbic acid supplementation in catfish (Li
and Lovell, 1985) reduced mortality rates caused by Edwards
iella ictaluri from 100% to 0%. Ascorbic acid deficiency in
these fish impaired Ab production and phagocytosis. High
concentrations of ascorbate (3000 mg/kg) supplementation to
these fish significantly enhanced Ab production and complement
activity.
Ascorbic Acid Supplementation and Immunity in Ruminants
The development of cell mediated immunity has been
investigated for lambs and calves (Outtridge, 1985, Manak,
1986) . Prenatal removal of the thymus in lambs created
immunodeficiency in those lambs. Resulting lymphopenia
possibly was due to depletion of a particular population of
T-cells that have a reduced mitogenic response and decreased
numbers as the lamb grows. Non-thymectomized lambs are less
responsive to vaccinations than are adult sheep due to
immaturity of the cell mediated immune response as well as
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high and low responder differentiations among the lambs
(Otterridge, 1985)
Manak (1986) studied the blastogenic responses of
lymphocytes of young calves to Con A, PHA and PWM. The serum
of young calves had a suppressive effect when incubated with
lymphocytes from older calves. Serum Cortisol was 3 mg/ml
at 6 hours and decreased to 5.5 mg/ml by 10 days of age. The
results indicate that the blastogenic response of the newborn
calf is suppressed relative to that of the 10 day old calf and
it is mediated primarily by serum factors. Other factors,
present in fetal serum, that may play a suppressive role are
a-fetoprotein, transferrin, fetiun or some T or non-T cell
suppressor population.
Itze (1984) found poor herd health; increased still
births, high early mortality, emergency slaughter and carcass
rejection at slaughter associated with low serum ascorbic acid
content. Several cases of hypo-gamma-globulinemia were found,
but no statistically significant correlations between ascorbic
acid concentrations and immunoglobulin concentrations could
be derived. Simco (1983), cited by Itze (1984) has suggested
that respiratory diseases in calves are aggravated by
environmental factors, long lasting transportation,
unfavorable microclimate and vitamin A and C deficiencies.
With 10 or 5 g/day supplementation of ascorbic acid, enteric
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and respiratory disease symptoms were reduced from those of
control calves. Parenteral administration of ascorbic acid
also resulted in lower morbidity. Vitamin C supplementation
had no effect on gamma-globulin concentrations.
The relationship of ascorbate, colostral nutrition and
Ig in serum of calves was studied by Itzeova (1984) . Great
differences in ascorbate content have been reported in milk
for dairy cows of the same age, stage of lactation, and
uniform management conditions. Ascorbic acid content in cow's
colostrum and milk is low compared to non-ruminant species
(Wegger and Moustegaard, 1982) . Ascorbate in milk after
removal from the cow is easily affected by oxidants and
irradiation. Heating and air can further lower the low
ascorbate present in cow's milk. Up to 20% of ascorbate in
milk is lost by drying. Addition of lactic acid-producing
microbes can increase the ascorbic acid content of sour milk.
Therefore, under most conditions it is possible that the young
calf may have a marginal ascorbic acid deficiency (Wegger and
Moustgaard, 1982)
.
Itzeova (1984) investigated the effect of the quality of
colostrum and the frequency of feeding of colostum on Ig
concentrations. Treatments were: 1) fresh colostrum from dam
two times per day, 2) fresh colostrum from dam three times per
day, 3) fresh colostrum two times per day and frozen colostrum
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from first milking one time per day, 4) one day frozen
colostrum of first milking three times per day, 5) one day
fresh colostrum from dam two times per day and frozen
colostrum of first milking one time, day two and three frozen
mixed colostum of first through fourth milking three times per
day, and 6) one day fresh colostrum from dam, day two and
three frozen mixed colostrum three times per day. Feeding
fresh colostrum two times per day or one time per day frozen
colostrum of the first milking avoided the decrease in plasma
ascorbic acid concentration typically seen after birth. No
vitamin C in the colostrum was lost due to freezing. All
treatments maintained normal Ig concentrations (Itzeova,
1984) .
In 1984 Blair and Cummins found increased IgG
concentration with ascorbic acid supplementation when calves
were deprived of colostrum. A later similar investigation
(Cummins and Brunner, 1989) showed lower IgG concentration
at 14 and 28 days for calves fed ascorbic acid. Calves fed
ascorbic acid had lower clinical scores for diarrhea. In this
study dietary ascorbate was not immunostimulatory in dairy
calves at 56 days and appeared to inhibit Ab synthesis,
although at 14 days plasma IgG concentrations were higher in
colostrum deprived calves supplemented with ascorbic acid than
in colostrum deprived calves without ascorbic acid
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supplementation. Roth and Kaeberle (1985) provided some
evidence for the use of ascorbic acid in counteracting the
immunosuppressive effect of Cortisol, although in later notes
they gave several reasons that the ascorbic acid treatment
might be futile in stressed animals, but felt the use of
ascorbic acid should be evaluated under field conditions in
stressed cattle (Roth and Kaeberle, 1986). Reddy et al.
(1986; 1987) and Cipriano et al. (1982) have established that
vitamin E increased the immune response of calves by 6 week
of age. Little research has been published regarding the
effects of vitamin C on lymphocyte and neutrophil function of
young calves. Based upon the uncertainty of the vitamin C
content of cows milk and the possible hypovitaminosis C state
of young calves, the effect of supplemental vitamin C alone
and vitamins C and E together on the growth and health of
young calves merits further investigation.
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THE EFFECT OF ROUTE OF ADMINISTRATION OF LASALOCID
ON RESPONSE OF YOUNG DAIRY CALVES
INTRODUCTION
Feeding lasalocid to neonate calves through twelve weeks
of age has resulted in increased feed intake and weight gain
(Anderson et al, 1988) . The greatest feed intake and weight
gain differences were in the last six weeks. The lasalocid-
fed group in that study received lasalocid in the milk,
prestarter and starter. However, it could not be determined
from which part of the diet the lasalocid delivery was having
the greatest effect. Early-weaned calves have shown metabolic
signs of earlier ruminal development than control calves
(Anderson et al., 1987 a,b). Early weaning leads to early
development of ruminal flora (Anderson et al., 1987 a,b.,
Lengemann and Allen, 1959) . The use of ionophores to
encourage early feed consumption and early weaning may have
economic and logistical benefits due to decreased labor and
feed costs associated with early weaning.
The objective of this study was to determine the most
effective method of administration of lasalocid. To allow for
differing early feed consumptions, a weaning program was used
in which weaning was based upon dry feed consumption.
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METHODS AND MATERIALS
Forty Holstein bull calves were removed from their dams
at 24 h of age and fed colostrum until 3 d of age. The calves
were blocked by date of birth and the four calves within each
block randomly assigned to one of four treatment groups.
Treatments were feeds with no lasalocid (None) ; feeds with
lasalocid in starter only (S) ; feeds with lasalocid in
prestarter and starter (PS,S) ; or feeds with lasalocid in
milk, prestarter and starter (M,PS,S). The calves in the
group receiving lasalocid in milk, prestarter and starter
received untreated prestarter and starter until two wk of age,
then they received lasalocid-treated prestarter and starter.
The lasalocid for this group was delivered in the milk on d
4 through 14 to provide 1 mg/kg of birth weight daily.
Lasalocid concentrations in the feed were 176 mg/kg in the
prestarter and 29 mg/kg in the starter, with a target
consumption of 1 mg/kg of body weight per day. Tables 1 and
2 show composition of prestarter and starter used.
Milk was fed at 8% of birth weight daily, divided into
two equal feedings, and prestarter was available beginning on
experimental day one. Milk was fed at that rate until the
calf consumed 227 g of prestarter per day. The afternoon
feeding of milk was discontinued at that time and as much
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1TABLE 1. Composition of prestarter.
Ingredient Percent
Whey, dried 46
2
Fat Supplement 23
Skim milk, dried 19
Sodium Caseinate 12
3
Additives +
1
Calfweena, Merricks, Union Center, Wi.
2
A mixture of milk solids and fat containing 7% milk protein
and 60% animal fat.
3
Includes chlortetracycline (200g/ton), preservatives,
vitamins, minerals, flavoring compounds, and lasalocid if added.
1,2.
TABLE 2. Composition of starter.
Ingredient Percent
Alfalfa, ground 25
Oats 20
Corn, cracked 32
Soybean meal 14.4
Molasses, liquid 5
Dicalcium phosphate 0.7
Limestone,ground 0.7
Salt 0.3
Trace Mineral Salt 0.3
Vitamins 3 +
Selenium (0.02%) +
Lasalocid (15% Active)
1 As-fed basis.
2 Pellet, 4.8 mm diameter.
3 2,200 lU/kg vitamin A, 330 lU/kg vitamin D, 77 lU/kg vitamin E,
and 1.0 mg/kg selenium.
4
Starter with lasalocid. 4
starter as the calf would consume was added to 227 g of
prestarter each day. When daily dry feed (prestarter plus
starter) consumption was at 1.3% of birthweight the calf was
weaned. Prestarter was discontinued at 5 weeks of age and
only starter was fed. Calves were housed in individual
hutches with straw bedding and given free access to water.
Sample Collection and Analysis. Daily feed intake and weekly
weight gains were recorded. Fecal scores were recorded twice
daily using the scale described by Larson et al . (1977).
Serum samples were taken at 4, 8, and 12 weeks for metabolic
evaluation using the SMA-12 analysis. Constituents determined
2by this analysis were Na, K, CI, CO
,
glucose, blood urea
nitrogen (BUN) , creatinine, alkaline phosphatase (ALP) , total
protein, albumin, globulin, albumin to globulin ratio (A/G)
,
Ca, and P.
Statistical Analysis. Data were analyzed as a randomized
complete block design, with treatment as the main source of
variation, using the General Linear Model Procedure
(SAS,1985). Means were tested for treatment and treatment by
time effects. LS means were separated using a protected least
significant difference test when significant treatment or
treatment by time effects were detected.
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RESULTS AND DISCUSSION
Table 3 shows daily lasalocid intake by week for each
treatment. The lasalocid intake varied by treatments across
time as was intended by the design of the experiment. The
greatest intake (mg/kg/day) occurred in calves receiving
lasalocid in M,PS,S at week 5. Calves with lasalocid
administered in all three feeds reached 1.00 mg/kg ± .05 by
the second week, those receiving lasalocid in PS,S reached
the same point by week 5 and calves with S only administered
lasalocid reached target lasalocid intake by week 10. At week
7, calves on all three treatments were consuming similar
amounts of lasalocid. The M,PS,S lasalocid-fed group showed
a decline in lasalocid intake when lasalocid was discontinued
in the milk and again when the prestarter, containing higher
levels of lasalocid than the starter, was discontinued.
Calves with lasalocid in PS,S also showed the decrease in
daily lasalocid intake after week 5 when lasalocid prestarter
was discontinued.
Cumulative dry feed intake for all treatments can be
seen in Table 4. The intake of calves with M,PS,S lasalocid
delivery was greater (P<.10) than for calves on the other two
lasalocid treatments at weeks 4, 5, and 6 and greater in wk
3 than those with lasalocid delivery in PS,S. There were no
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TABLE 3. Daily lasalocid intake (mg/kg of body weight/day)
and body weight (BW, kg) of calves.
Lasalocid Administration
None
BW
M.PS.S 1 PS.S S
wk Intake BW Intake BW Intake BW
l 45 .59 45 .21 45 47
2 44 .97 46 .35 46 .08 47
3 46 .91 48 .62 48 .07 50
4 49 1.14 50 .82 50 .19 51
5 54 1.32 56 1.11 54 .38 55
6 59 .85 63 .73 59 .73 62
7 66 .84 68 .84 64 .83 68
8 72 .94 74 .90 71 .91 76
9 77 .95 80 .95 77 .92 81
10 82 .92 87 .97 84 .97 87
11 91 .88 93 .95 91 .97 96
12 98 .94 102 .97 100 1.03 106
M=milk, PS=prestarter, S=starter.
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TABLE 4. Cumulative dry feed intake (kg)
AGE Lasalocid Administration Pooled
WK None M.PS.S 1 PS.S S SE
1 .5
2 1.5
3 4.4'
4 9.4'
5 18.1
6 30.3'
7 44.0
8 59.0
9 76.0
10 93.7
11 113.6
12 137.0
.5 .4
1.4 1.0
A /I 34 . 4 2.8
10. 2 a 6.4
2 0.
a 12.6
32.
7
a 23.0
45.7 34.9
62.1 49.8
80.3 67.4
99.4 85.3
119.6 105.7
142.7 128.7
.3
1.0
3.0
6.5*
13. 8 l
ab
24,
37,
53,
71,
90.8
112.8
138.1
13
30
63
37
41
31
44
5.08
5.77
6.98
8.19
9.12
a
'
b
means In the same row with differing superscripts
differ (P< .10)
.
1M=milk, PS=prestarter, S=starter.
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significant differences in feed intake, cumulative or weekly,
between treatments from weeks 7 through 12
.
The cumulative average daily gain (ADG) , Table 5, shows
significant differences at wk 2 , 3, 4, 6, and 7. Calves with
lasalocid in M,PS,S had equal to or greater cumulative ADG
than any of the other three treatments for all but wk 2 and
12. The body weights shown in Table 2 reflect a similar
pattern for the four treatments. The greater gains shown
during the first 4 wk by calves with lasalocid in M,PS,S and
then the calves with lasalocid in S may be attributed to
earlier weaning attained by these groups. The larger gains
at weeks 4-6 for calves fed lasalocid in M,PS,S may be due to
levels of lasalocid intake near 1.5 mg/kg of body wt. The
equal gains in wk 7-12 reflect similar levels of lasalocid
intake, near 1.0 mg/kg, for all treatment groups from wk 7 on.
This is discrepant with results of Anderson et al. (1988)
which showed gain differences between treatments during wk 7-
12. During the first 6 wk of that study, lasalocid intake was
< 1 mg/kg of body wt/day and reached 1.5 mg/kg/d during the
last 6 wk when the greatest weight gains were observed.
Therefore, in both studies greater weight gain was seen when
lasalocid consumption was > 1.0 mg/kg/d, regardless of age.
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TABLE 5. Cumulative daily gain (kg/d)
Age Lasalocid Administration Pooled
WK None M.PS.S 1 PS,S S SE
1 .30 .41 • 25
,h
.38 .070
2 • 13 b .24 a .16ab .24a .040
3 .17 b .27a .22 ab .27 a .039
4 .23 ab .30a • 22 b .26ab .035
5 .32 .39 .29 .33 .047
6 .41ab .50 a .36b .43 ab .044
7 .49ab • 52 a .41b .49
ab
.052
8 .53 .57 .49 .56 .038
9 .55 .60 .54 .58 .037
10 .57 .65 .55 .61 .039
11 .63 .67 .60 .67 .042
12 .67 .71 .66 .73 .044
a,b means in the same row without a common superscript
differ (P< .10).
1M=milk, PS=prestarter, S=starter.
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Average daily gain and lasalocid intake for all
lasalocid-fed calves are shown in Figures 1, 2, and 3. Calves
with lasalocid delivered in M,PS,S gained more than calves on
the other two lasalocid administration treatments from weeks
2 through 6. The decrease between weeks 6-7 is present in all
three lasalocid treatments. Lasalocid administration in PS,S
appeared to lack the beneficial effect that delivery of
lasalocid in all three feeds had on gain. However, the gain
of calves with lasalocid in S only increased as the lasalocid
intake increased with starter consumption. The ADG of all
three lasalocid treatments reflect the lasalocid intake,
increased lasalocid intake followed by increased gain and
lasalocid decreases followed by stable or decreased gain.
Fecal scores (Figure 4) showed significant differences
at two different weeks. Week 4 fecal scores for the control
group were significantly greater (P<.10) than those of calves
fed lasalocid in M,PS,S. The fecal score of calves receiving
lasalocid in S only was different (P<.10) than for the other
three treatments at week 7. At week 2, a typical increase
in fecal scores was observed in all treatments. We observed
no incidence of coccidiosis during this study. This is
consistent with Anderson et al.(1988), who reported no
incidence of coccidiosis in conjunction with lasalocid
consumption. However, in contrast to our data, Anderson et
47
Figure 1. Daily gain and lasalocid intake of calves fed
lasalocid in milk, prestarter, and starter.
iM=milk, PS=prestarter, S=starter.
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Figure 2. Daily gain and lasalocid intake of calves fed
lasalocid in prestarter and starter.
1PS=prestarter, S=starter.
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Figure 3. Daily gain and lasalocid intake of calves fed
lasalocid in starter.
!S=starter.
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Figure 4. Mean weekly fecal scores for calves receiving
lasalocid in M,PS,S; PS,S; S; or none. Differing
superscripts within the same week denote means with
statistically significant differences (P<.10).
1M=milk, PS=prestarter, S=starter.
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al. (1988) did not observe differences in fecal scores.
Days required to reach the criterion for A.M. only
feeding (Figure 5) show significant differences between the
control group, as well as the group receiving lasalocid in
M,PS,S, and those with lasalocid delivery in S only.
Significant differences between calves with lasalocid in
M,PS,S and the other two lasalocid fed groups were seen for
days to weaning (P<.10). The standard deviation for calves
with lasalocid delivered in M,PS,S was least for days to A.M.
only and significantly less for days to weaning than the other
treatments . Standard deviations for days to A.M. only were;
8.0, 5.8, 11.0, and 10.8, and for days to weaning were; 5.9,
2.8, 8.2, and 6.5 for lasalocid delivery in none; M,PS,S;
PS,S; and S respectively. This study demonstrated a greater
consistency for calves fed lasalocid in milk, prestarter and
starter to achieve earlier 1 X daily feeding and weaning,
probably due to earlier rumen development. Anderson et al.
(1988) investigated the value of lasalocid for stimulating
rumen development, thereby increasing dry feed consumption and
utilization and allowing earlier weaning. Early weaning
stimulated earlier dry feed consumption which led to early
development of rumen microflora (Anderson et al., 1987 a,b) .
The rumen microbes of early weaned calves contained high
numbers of methanogens, leading to increased methanogenesis,
52
Figure 5. Days required to reach criterion for 1 time daily
feeding and weaning for calves fed lasalocid in
M,PS,S;PS,S; S; or none. Differing superscripts within
the same week denote means with statistically significant
differences (P<.10).
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possibly reducing efficiency of weight gain (Thornton and
Owens, 1981) . The data in Figure 5 suggests that, not only did
it assist calves that are weaned early, but when delivered in
M,PS, and S, lasalocid encouraged earlier weaning.
Results of blood metabolite analyses are shown in Table
6, 7 and 8. Differences among treatment groups were observed
for blood glucose and urea nitrogen concentrations at week 4
;
chloride, urea nitrogen, and creatinine concentrations at week
8; and chloride, urea nitrogen, creatinine, and potassium
concentrations at week 12 . The concentration of blood glucose
of calves fed lasalocid in M,PS,S at week 4 was lower than the
other groups 1 and urea nitrogen concentrations were higher.
These differences can be attributed to weaning and the onset
of rumen development, however the values were within the
normal range for bovine species. Blood urea nitrogen
increases as rumen fermentation increases. This is consistent
with the higher NH3-N values found in rumen fluid by Anderson
(1987b) for early weaned calves and for lasalocid fed calves
(Anderson et al., 1988). Lasalocid consumption in older
animals caused an increase in NH3-N concentrations. Studies
of older cattle have shown decreased blood glucose
concentration with lasalocid consumption (Scheling, 1984,
Spears and Harvery, 1982) and studies with young animals show
a decrease in blood glucose concentration up to 8 weeks of age
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TABLE 6. Blood metabolite analysis, week 4, of calves fed
no lasalocid, lasalocid in M,PS,S, lasalocid in PS,S, or
J.UOUiVViVA -»-±
Lasalocid Administration
Metabolite None M.PS.S 1 PS.S S
Creatinine .98 1.05 1.07 1.04
(mg/dL)
Potassium 5.3 5.4 5.3 5.4
(mmol/L)
Chloride 103. 104. 102. 103.
(mmol/L)
Glucose 84. ab 74." 82.
ab 88. b
(mg/dL)
BUNZ 13.1ab 16. a 12. 7
b 12. 3 b
(mg/dL)
Sodium 140. 141. 140. 140.
(mmol/L)
co2 25.2 24.7 24.6 25.2
(mmol/L)
ALP3 103. 116. 117. 138.
(U/L)
Total
Protein 5.5 6.0 5.5 5.8
(g/dL)
Albumin 3.1 3.1 3.1 3.2
(g/dL)
Globulin 2.4 2.9 2.4 2.6
(g/^L)
A:G4 1.3 1.1 1.8 1.2
Calcium 10.5 10.5 10.4 10.6
(mg/dL)
Phosphorus
(mg/dL)
7.8 7.7 7.7 7.9
aDCmeans in the same row with differing superscripts differ
(P< .10)
M=milk, PS=prestarter, S=starter.
2BUN=blood urea nitrogen.
ALP=alkaline phosphatase.
4A:G=albumin to globulin ratio.
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(Otterby and Linn, 1981)
.
Urea nitrogen at week 8 was highest for the control group
and lowest for calves with lasalocid administered in PS,S.
These data are consistent with the feed consumption and
weaning data, all of which reflect rumen development. The
control group was the second group to attain weaning criteria
and second to increase feed consumption. The serum chloride
concentration of the control group at week 8 was high and out
of the normal range for the adult bovine. Creatinine for
calves with lasalocid in PS,S was below the normal range at
week 8, however this is not unusual for calves in confinement.
At week 12 blood urea nitrogen concentration was high and
chloride concentration was above the normal range for control
calves. The group fed lasalocid in PS,S had significantly
lower chloride concentration, but the concentration was within
the normal range. Creatinine at week 12 was below the normal
range for adult bovine for the PS,S lasalocid-fed group and
the control group. Potassium at week 12 was lowest for calves
receiving lasalocid in M,PS,S and highest for the control
group, but all fell within the normal range. These potassium
values appear to reflect the time the calves in the treatment
groups had been consuming lasalocid.
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TABLE 7. Blood metabolite analysis, week 8, of calves fed
no lasalocid, lasalocid in M,PS,S, lasalocid in PS,S, or
lasalocid in S.
Lasalocid Administration
Metabolite
Creatinine
(mg/dL)
Potassium
(mmol/L)
Chloride
(mmol/L)
Glucose
(mg/dL)
BUNZ
(mg/dL)
Sodium
(mmol/L)
C02
(mmol/L)
ALP3
(U/L)
Total
Protein
(g/dL)
Albumin
(g/dL)
Globulin
(g/£L)
A:G
Calcium
(mg/dL)
Phosphorus
(mg/dL)
None
83blib
5.2
104. b
89.
9.9 C
142.
25.1
363.
5.6
3.2
2.3
1.4
11.1
8.0
M.PS.S
ab
.81*
5.0
100. a
93.
9.5
141.
25.7
292.
5.8
3.2
2.7
1.2
11.2
8.7
PS.S
77'
.88 l
5.0 5.1
102. ab 102. ab
90. 90.
7.6a 9.2 a
142. 143.
26.1 24.8
272. 326.
6.0 5.8
3.2 3.2
2.7 2.6
1.2 1.3
11.3 11.2
8.6 8.6
b
aDCmeans in the same row with differing superscripts differ
(P< .10)
.
^^milk, PS=prestarter, S=starter.
BUN=blood urea nitrogen.
ALP=alkaline phosphatase.
A:G=albumin to globulin ratio.
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TABLE 8. Blood metabolite analysis, week 12, of calves fed
no lasalocid, lasalocid in M,PS,S, lasalocid in PS,S, or
lasalocid in S.
Lasalocid Administration
Metabolite None M.PS.S
Creatinine .74
(mg/dL)
Potassium 4.99
(mmol/L)
Chloride 103. b
(mmol/L)
Glucose 106.
(mg/dL)
BUNZ 13. 3 b
(mg/dL)
Sodium 145.
(mmol/L)
co2
(mmpl/L)
ALP3
26.0
312.
(U/L)
Total
Protein 6.0
(g/dL)
Albumin 3.5
(g/dL)
Globulin 2.4
(g/dL)
A:G4 1.5
Calcium 11.6
(mg/dL)
Phosphorus
(mg/dL)
8.8
.84'
4.72 J
102. ab
106.
9.2 a
145.
26.4
362.
6.6
3.6
3.0
1.2
11.6
8.7
PS.S
75yk~ 81ab
4 . 74 4.93
99. a 101. ab
102. 109.
9.9 a 9.5 a
140. 142.
25.2 25.5
274. 412.
6.1 6.2
3.4 3.6
3.0 2.6
1.2 1.4
11.3 11.4
8.6 8.6
be
aDC
means in the same row with differing superscripts differ
(P< .10) .
1M=milk, PS=prestarter, S=starter.
2BUN=blood urea nitrogen.
3ALP=alkaline phosphatase.
4A:G=albumin to globulin ratio.
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CONCLUSIONS
Lasalocid delivery in milk, prestarter and starter
promoted early weaning with less variability. Although the
control group had the same mean number of days to reach
criterion for weaning, there was a greater variation in that
group. Calves receiving lasalocid in all three feeds showed
increased ADG during wk 4-6 and egual to or greater ADG during
wk 1-11 than calves receiving no lasalocid, lasalocid in PS
and S, or S only. The feed intake of the group with lasalocid
in all three feeds was greater than the other treatment groups
throughout the twelve weeks of the experiment.
Lasalocid in PS and S was less effective than either
lasalocid in milk, prestarter, and starter, or in starter
only. Delivery at approximately 1.5 mg/kg of body weight
appeared to be most effective, based on these data and those
of Anderson et al. (1988) . These data suggest that for use
with young calves, lasalocid should be delivered in all three
feeds. Further investigations of the most effective dosage
levels are needed.
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EFFECT OF SUPPLEMENTAL VITAMINS C AND E
IN MILK REPLACER
ON GROWTH AND HEALTH IN BULL CALVES
INTRODUCTION
Ascorbic acid is produced by the liver of many animals,
including cattle. Lundquist and Phillips (1942) believed that
ascorbic acid synthesis begins in calves between the second
and third week of life and Bouda et al. (1980) established
that adult levels of vitamin C are not present in the calf
until after 3 months of age.
Milk, which has with a relatively low ascorbic acid
content (Wegger and Moustgaard, 1982) is often exposed to air
and light before being consumed by the calf. Both are
destructive agents of vitamin C and therefore the milk may
not contain adequate vitamin C for the calf. Hypovitaminosis
C is therefore a potential problem with the young milk fed
calf. This would be especially true for dairy calves whose
only source of vitamin C for the first few weeks of life is
bucket or bottle fed milk or milk replacer.
Vitamin C deficiency has been linked to compromised
immunocompetence and elevated ascorbic acid concentrations
have been linked to increased immune response in catfish (Li
and Lovel, 1985, Durve and Lovell, 1982) poultry (Moffat et
al., 1972, Ghoshal and Bhattacharyga, 1985, Thaxton and
Pardue, 1984), cattle (Roth and Kaeberle, 1985, Blair and
Cummins, 1984) and swine (Kristensen et al . , 1986).
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Conversely, others have found that vitamin C supplementation
had no beneficial effect on the immune parameters measured
(Siegel and Morton, 1984, Bendich et al . , 1984, and Cummins
and Brunner, 1989)
.
The value of vitamin E to the immune system of the young
calf has been established (Cipriano et al., 1982, Reddy et
al., 1986; 1987). The value of vitamin C and E
supplementation together has been supported for other species
(Bendich et al., 1984, Anderson, 1981, Packer et al., 1979,
and Niki et al., 1982). Vitamin E is primarily responsible
for protection of the cell membrane. As vitamin E interacts
with free radicals at the membrane, it is reduced. A high
concentration of vitamin C at the cell membrane is thought to
regenerate the reduced vitamin E created during the oxidation-
reduction process, which increases the available concentration
of vitamin E (Bendich, 1987) . Therefore, vitamins C and E
work cooperatively to protect the cell membranes against
peroxidation.
The purpose of the present study was to determine the
effects of supplemental vitamin C alone and vitamins C and E
together on the function of neutrophils and lymphocytes of
the young calf's immune system, as well as their effect on the
growth and general health of the calf during the first 8 wk
of life.
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MATERIALS AND METHODS
Thirty Holstein bull calves were removed from their dams
at 24 h following birth. They were given transition milk for
two more d then assigned to a block by date of birth. Calves
within each block were randomly assigned to one of three
treatment groups. The treatments consisted of milk replacers
containing 1) no supplemental vitamin C or E, 2) lOg
vitamin C per kg and no supplemental vitamin E, 3) lOg
vitamin C and 57 IU vitamin E per kg. The basic milk replacer
was an all milk, milk replacer with the following analysis:
45% lactose, 20.1% protein, 20.3% fat, 6.7% ash, 4170 Kcal/kg
energy, 2.3 IU/kg vitamin E, and vitamin C
1
.
Calves were
bottle fed to increase the probability of rumen bypass for the
eight wk of the study. Milk replacer was reconstituted to
13.5 % dry matter and was fed in two egual daily feedings at
10% of body weight, adjusted weekly. Calves were housed in
individual hutches with straw bedding. Water was available
ad libitum.
Body weights were measured and milk replacer allocations
were adjusted weekly. Twice daily fecal (Larson et al., 1977)
and general appearance scores were recorded, and checks for
eye or nasal discharge or signs of enteric or respiratory
*Milk Specialties Company, Dundee, IL. 60118
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illness were noted. Blood samples were collected in
heparinized tubes on experimental d 1, 14, 28, and 56 for
vitamin C and E determinations. Day 14 and 28 samples were
used to assay lymphocyte proliferation and neutrophil
function. A lymphocyte transformation assay (LTA) , and
antibody-dependent cellular-cytotoxicity (ADCC) and S. aureus
phagocytosis assays were used to determine lymphocyte cellular
function.
Lymphocyte and Neutrophil Isolation and Cryopreservation
All blood samples were kept on ice until reaching the
lab. Whole blood samples were centrifuged at 700 x g for 10
minutes and the plasma was removed and frozen (-2 0° C) for
later determination of vitamins C and E. Isolation and
proliferation of mitogen-stimulated peripheral blood
mononuclear cells (PBMC) were measured as previously described
(Blecha and Baker, 1986) . Briefly, 30 ml of heparinized blood
were centrifuged at 600 x g for 15 min at 25°C. The buffy
coat, diluted 1:2 with RPMI, was layered onto ficoll/sodium
diatrizoate (Histopague-1077) 2 . The remaining red cell layer
was saved in an ice bath for neutrophil isolation. After
centrifugation at 400 x g for 40 min at 25 °C, the mononuclear
2Sigma Chemical Co., St. Louis, MO 63178
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cell layer was collected. Cells were then washed three times
in RPMI, counted and suspended at 2.5 x 10
6 cells/ml in RPMI
supplemented with 2 0% FBS, MEM-nonessential amino acids, MEM
essential amino acids, MEM vitamins, 1 mM sodium pyruvate, 2
mM L-glutamine, 100 U/ml penicillin, 100 /xg/ml streptomycin,
fungizone, 24 mM NaHC03 , 10 mM HEPES (cDMEM)
3 and 10%
dimethylsulfoxide (DMSO) according to methods previously
described (Kleinschuster et al., 1979, Kuil, 1984, Birkeland,
1976, and Takahashi et al., 1985). The cells were frozen
immediately in a Que Cryostar at -135° C.
Neutrophil isolation and antibody-dependent cellular-
cytotoxicity (ADCC) assay procedures were a modification of
the methods of Rouse et al . , (1976) and Roth and Kaeberle,
(1981a, b). The red cell layer was lysed by suspension in 10
ml cold sterile deionized water for neutrophil separation.
An egual volume of RPMI was added to restore isotonicity. The
cells were centrifuged at 700 RPM at 4° C for 10 min. This
lysis procedure was repeated two more times. Throughout the
procedure all media and tubes were kept in an ice bath. The
neutrophils were frozen as described for the lymphocytes.
Thawing procedures were modifications of those described
by Kleinschuster et al . (1979). Briefly, cells, either
3GIBC0, Grand Island, NY 14072.
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neutrophils or lymphocytes, were placed in a 37° C water bath
just until the last crystal melted. The cells were added to
5 ml RPMI and centrifuged, lymphocytes at 1600 RPM and
neutrophils at 700 RPM. Both cells were washed 2 more times
with RPMI . Five samples each from lymphocytes at 2 and 4 wk
and neutrophils at 2 and 4 wk were counted using Trypan Blue
exclusion method for viability. All cells were counted on a
Coulter Counter and lymphocytes adjusted for viability to 2
x 106 and neutrophils to 2.5 x 106 cells/ml.
Antisera Preparation
Two 3 mo old calves were hyperimmunized for three wk at
1 wk intervals with washed chicken red blood cells (CRBC) from
10 ml fresh chicken blood. Calf blood samples were collected
for sera separation at 1 and 2 wk following the final
immunization. Sera were heat inactivated (30 min in a 57 C
water bath) and frozen at - 20° C. Sera were later diluted
by a factor of 10 with RPMI and refrozen until thawed at 23°
C just prior to use in the ADCC assay.
Target Cells
Approximately 1 ml of whole chicken blood was collected
into a heparinized tube, then centrifuged at 1500 RPM for 15
min. The plasma and buffy coat were discarded.
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The CRBC were washed with RPMI 3 times. Two tenths cc sodium-
chromate was added to the CRBC and incubated for 3 h. The
cells were then washed 3 time in RPMI and counted for use in
the ADCC.
ADCC Procedures
The labeled CRBC were diluted to 100,000 cells/ml for a
25:1 effector to target ratio. Spontaneous release mixture,
(.1 ml CRBC and .1 ml RPMI), maximum release mixture, ( . 1 ml
CRBC and .1 ml Triton), and reaction mixtures, ( . 1 ml CRBC,
20 Ml CRBC antibody, and .1 ml neutrophils), were each added
to three wells of a 96 well Costar microtiter plate. The
cells were incubated at 37° C for 18 h. The supernatant was
harvested and the gamma emissions counted. Results were
expressed as a percent of specific release with:
Percent specific release =
mean CPM test release - mean CPM spontaneous release x 100
mean CPM maximum release-mean CPM spontaneous release
Lymphocyte Transformation Assay (LTA)
Proliferative responses to mitogens were evaluated by
incubating 100 jLtl of PBMC at 2.5 x 106 cells/ml with 100 /xl of
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concanavalin A (20 /ig/ml) 4
,
phytohemagglutinin (10 fig/ml) , and
pokeweed mitogen (100 fj.l/ml) 6 for 66 hours in a humidified 93%
air-7% C02 atmosphere. Tritiated thymidine (20 ill at 0.075
/iCi//il, sp act. =6. 7 Ci/mM) 7 ; was added for the last 18 hours
of incubation. Cells were harvested onto filter paper for
Q
liguid scintillation spectrophotometry with an automated cell
qharvester
Vitamin C Determination
A modification of the method of Albanese, et al. (1975)
was used for vitamin C analysis. Modification was the use of
4 ml 3 0% Trichloroacetic acid (TCA) to extract ascorbic acid
from 1 ml plasma sample, due to low concentrations of ascorbic
acid in samples. Briefly, 1 ml plasma was added to 4 ml 3 0%
TCA and centrifuged at 2500 RPM for 10 minutes. One ml of
4Pharmacia Inc., Piscataway, NJ.
5Burroughs Wellcome Co., Research Triangle Park, NC.
6GIBC0, Grand Island, NY.
7ICN Chemicals, Irvine, Ca.
8Packard Tri-carb, model 4450, Packard Instrument Co.,
Downers Grove, II.
9PHD Cell Harvesting System, model 200A, Cambridge
Technology Inc. , Cambridge, MA.
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tenths ml of 2-4 dinitrophenylhydrazine was added to each
tube, the tube was stoppered, and heated for 20 min in a 90
C water bath. The tubes were cooled for 5 min in an ice bath.
One and one half ml 65% H2S04 was added to each tube.
Absorbance was then determined on a spectrophotometer at 520
nm.
S. aureus Phagocytosis
Staph aureus phagocytosis was conducted as described by
Roth and Kaeberle (1981a). Briefly, heat killed
3H-Glycine-
labeled S^_ aureus cells were mixed with neutrophils and
incubated for 10 min at 37°C. Lysostaphin was then added and
the mixture incubated for 3 min more. The cells were washed
twice in phosphate buffer saline and the radioactivity of the
remaining pellet was determined in a gamma counter. Results
were expressed as a percent of total S^. aureus ingested with:
Percent ingestion =
(CPM in reaction tubeWCPM in background tube) x 100
(CPM in standard tube)-(CPM in background tube)
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RESULTS AND DISCUSSION
Milk Replacer Vitamin Concentration Verification
To check stability of vitamin C in milk replacers,
samples were collected for analysis from an unopened bag older
than one month, an unopened bag less than two weeks old, and
from a covered bucket in which the milk replacer was stored
for daily use. Results are in Table 1. All control milk
replacer samples had about 1 mg/kg of vitamin C concentration.
The samples of milk replacers with vitamin C only (10 mg/kg)
had about 7.0 mg/kg vitamin C concentration. The mix with
both vitamins C and E taken directly from the bags had less
oxidation of the vitamin C (7.6 and 9.0 mg/kg) while the mix
from the bucket was similar to that of all the vitamin C only
mixes.
Daily Health and Growth
Plasma vitamin C and E concentrations for wk 0, 2, 4,
and 8 are in Figures 1 and 2 . The plasma vitamin C
concentration of the control group dropped gradually through
week 4 and then returned to approximately the same
concentration as all other treatments by week 8. The group
receiving vitamin C in the milk replacer began with a greater
concentration of plasma vitamin C and gradually fell at week
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Figure 1. Plasma vitamin C concentrations at 0, 2, 4, and 8
weeks for calves supplemented with vitamin C and
vitamin E, 10 g/kg vitamin C and vitamin E, or 10 g/kg
vitamin C and 57 IU/kg vitamin E.
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Figure 2. Plasma vitamin E concentrations at 0, 2, 4, and 8
weeks for calves supplemented with vitamin C and
vitamin E, 10 g/kg vitamin C and vitamin E, or 10 g/kg
vitamin C and 57 IU/kg vitamin E. Differing
superscripts within the same week denote means with
statistically significant differences. a 'b (P < .05. c '
(P < .10)
.
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2 and wk 8, reaching the same concentrations as the other two
groups at week 8. The group with vitamins C and E
supplementation in the milk replacer showed a large decrease
in plasma vitamin C concentration by week 2 . This group
showed a large rebound in plasma vitamin C concentration at
week 4 which then returned to the same concentration as the
other groups by week 8 . The values reported here are low
compared to previous reports of vitamin C concentration of
young calves. However, in this study, all samples were taken
3 minutes prior to feeding, which is the lowest point of
vitamin C concentration during the day. The plasma samples
did not contain any antioxidant during freezing which may
account for some of the reduced concentrations.
Plasma vitamin E concentrations reflected the
supplementation of that vitamin. A similar pattern of vitamin
E plasma concentration occurred E plasma concentration
occurred for the control calves and the calves supplemented
with only vitamin C. A slight increase at week 2 and a
continued decrease throughout the experiment of plasma vitamin
E concentration was seen in both groups. It appears vitamin
C had no effect on the vitamin E plasma content at this low
concentration. The vitamin C and E supplemented group,
although beginning at a higher level, had significant
increases in plasma vitamin E concentrations at wk 2 , 4 , and
74
8 above that of the control and of the vitamin C only groups.
Total gain, overall feed efficiency and, total ocular
and nasal discharge data are presented in Table 2. The net
gains of the calves on treatments were not significantly
different from the net gain of the control calves. However,
the smaller gains of the vitamin C supplemented calves were
statistically different from the increased gains of the
vitamin C and E supplemented group. The net feed efficiency
was determined by calculating kg dry weight of milk replacer
fed per kg gain. The net efficiency of the vitamin C and E
supplemented group was significantly lower, indicating greater
feed efficiency, than those of the vitamin C supplemented
group or of the control group. The three groups performed
similarly in daily gain through wk 5, except for a decrease
of the vitamin C and E supplemented group at wk 3. Weekly
average daily gain (Figure 3) showed significant differences
at week 6 and 8 between the two treatment groups and a
significant difference between the vitamin C and E
supplemented calves and the control calves at week 7. The
vitamin C and E group showed more variation between weeks
throughout the eight weeks while the vitamin C group deviated
from the control group only at week 6.
Feed efficiency data (Figure 4) show no differences
between treatments until week 6 and 7. At week 6 vitamin C
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Figure 3 . Average daily gain of calves supplemented with
vitamin C and vitamin E, 10 g/kg vitamin C and
vitamin E, or 10 g/kg vitamin C and 57 IU/kg vitamin E.
Differing superscripts within the same week denote means
with statistically significant differences (P < .10).
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Figure 4. Feed efficiency of calves supplemented with
vitamin C and vitamin E, 10 g/kg vitamin C and
vitamin E, or 10 g/kg vitamin C and 57 IU/kg vitamin E.
Differing superscripts within the same week denote means
with statistically significant differences (P < .10).
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supplementation group was statistically different from the
control and the vitamin C and E supplemented group. At week
7 the vitamin C and E group was significantly different from
the control and vitamin C only groups. It was at week 7 that
a decrease in ADG was seen for that group as well.
Figure 5 shows weekly mean fecal scores for all groups.
The control group tended to have the lowest fecal scores
throughout the 8 wk and the vitamin C supplemented group
tended to have the highest scores. The control and vitamin
C supplemented groups were statistically different (p<.10) at
wk 2, 6, and 8, and at week 8 the vitamin C group was also
significantly higher than the vitamin C and E supplemented
group
.
Mean eye and nose discharge observations tended to be
higher for the control group for all 8 wk (Figure 6) . At week
3 the vitamin C and E supplemented calves had significantly
lower observations of discharges than the control group and
the vitamin C only supplemented group was significantly
different than the control calves at week 7.
Cryopreservation and Fresh Cell Comparisons
The reductions in function of cryopreserved cells from
that of fresh cells are shown in Table 3. Both lymphocytes
and neutrophils demonstrated acceptable percentages of
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Figure 5. Fecal scores of calves supplemented with vitamin
C and vitamin E, 10 g/kg vitamin C and vitamin E, or
10 g/kg vitamin C and 57 IU/kg vitamin E. Differing
superscripts within the same week denote means with
statistically significant differences (P < .10).
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Figure 6. Ocular and nasal discharge of calves supplemented
with vitamin C and vitamin E, 10 g/kg vitamin C and
vitamin E, or 10 g/kg vitamin C and 57 IU/kg vitamin
E. Differing superscripts within the same week denote
means with statistically significant differences (P<.10) .
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viability, 90% and 92% for neutrophils and lymphocytes,
respectively. The percent reduction of lymphocyte
proliferation in response to Con-A mitogen from fresh to
frozen cells was similar across treatments. The PHA mitogen
stimulated lymphocytes and the neutrophils were similar in
percent reduction of function for the control and vitamin C
supplemented groups. There was less reduction of cellular
function of cells from calves supplemented with vitamins C and
E. This was true for both neutrophils and lymphocytes
stimulated with PHA. The cryopreserved lymphocytes stimulated
with PWM displayed a great variability from the response of
fresh cells, some increasing and some decreasing from the
fresh cell response, resulting in a reduction in function
overall. It appeared from these data that neutrophils and
lymphocytes stimulated with Con-A and PHA were predictably
effected by cryopreservation. However, the data obtained
with the use of cryopreserved cells stimulated with PWM are
questionable due to the great variability in response of cells
following cryopreservation as well as the mean differences
between treatments for percent reduction in function.
Immune Function
Lymphocyte transformation assay results appear in Figures
7, 8, and 9. Due to the variability in the lymphocyte
83
Figure 7. Lymphocyte proliferation with concanavalin A
mitogen for calves supplemented with vitamin C and
vitamin E, 10 g/kg vitamin C and vitamin E, or 10 g/kg
vitamin C and 57 IU/kg vitamin E.
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Figure 8. Lymphocyte proliferation with phytohemagglutinin
for calves supplemented with vitamin C and vitamin
E, 10 g/kg vitamin C and vitamin E, or 10 g/kg vitamin
C and 57 IU/kg vitamin E.
85
XL
O
Figure 9. Lymphocyte proliferation with pokeweed mitogen for
calves supplemented with vitamin C and vitamin E, 10
g/kg vitamin C and vitamin E, or 10 g/kg vitamin C and
57 IU/kg vitamin E.
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functions of the 2 and 4 week old calf no significant
differences between the treatment groups can be noted in the
Con-A and PHA mitogen induced proliferation means. Week 2
lymphocytes of vitamin C and E supplemented calves had greater
proliferation. By week 4 the lymphocytes of vitamin C vitamin
supplemented calves had equal to or greater proliferative
responses than that of the C and E supplemented calves. The
PWM responses had extreme variability within each group and
did not appear to be a good measure for these calves.
The neutrophil mediated ADCC at week 2 (Figure 10) showed
significant differences between the vitamin C supplemented
group and the control at week 4, and between the two vitamin
supplemented groups at week 2. The same cells used in SLl
aureus phagocytosis assays showed the vitamin C group
significantly different from the control a week 2, but no
significant differences were detected at week 4 with this
measure (Figure 11) . However the same trend as seen in the
ADCC is evident at week 4
.
CONCLUSION
The supplementation of vitamin C alone and vitamins C
and E together did not have a beneficial effect on any of the
immune responses measured here. However, the lower incidence
of mucous discharge suggests a beneficial effect that was not
87
Figure 10. Neutrophil-mediated antibody-dependent cellular
cytotoxicity % specific-lysis for calves supplemented
with vitamin C and vitamin E, 10 g/kg vitamin C and
vitamin E, or 10 g/kg vitamin C and 57 IU/kg vitamin
E. Differing superscripts within the same week denote
means with statistically significant differences (P<.10) .
88
-a
a
a
u
6
a
Figure 11. Neutrophil-mediated S_-_ aureus phagocytosis % kill
by neutrophils from calves supplemented with vitamin
C and vitamin E, 10 g/kg vitamin C and vitamin E, or
10 g/kg vitamin C and 57 IU/kg vitamin E. Differing
superscripts within the same week denote means with
statistically significant differences (P<.05).
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reflected by the cellular functions we measured. The use of
vitamins C and E together appeared to negate the adverse
effects of vitamin C alone on neutrophil functions at both 2
and 4 wk and on lymphocyte proliferation at wk 2. The
synergistic relationship of vitamin C and E and its effect on
the immune cell's functions and other possible roles of
vitamin C in the immune system merit further investigation.
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Measurements of the growth and health of young dairy
calves as influenced by lasalocid administration or vitamin
C and vitamins C and E supplementation were determined. Forty
Holstein bull calves were assigned to one of four treatment
groups; no lasalocid, lasalocid in starter, lasalocid in
prestarter and starter, or lasalocid in milk, prestarter and
starter for a twelve week trial period. Calves were fed milk
at 8% of birth weight daily divided into two egual feedings,
until they consumed 227 g of prestarter. Then the afternoon
milk feeding was discontinued and as much starter as the calf
would consume was added to the prestarter. When total dry
feed consumption was at 1.3% of birth weight the calf was
weaned. At five weeks of age the prestarter was discontinued.
Daily gain was greatest during the first six weeks for
the calves with lasalocid in milk, prestarter and starter.
The calves receiving lasalocid in milk, prestarter and starter
were weaned earlier with less variation. There were no
differences in gain by week twelve between the treatments.
Lasalocid in milk, prestarter and starter was the most
effective delivery of lasalocid of the three routes of
lasalocid administration given.
Thirty Holstein bull calves were bottle-fed one of
three milk replacers at 10% of weekly adjusted body weight
for eight weeks. Milk replacers were suplemented with
vitamins C and E at : (1) 0.0 and 0.0, (2) lOg and 0.0, or
(3) lOg and 57 IU/kg, respectively. Lymphocytes and
neutrophils isolated from blood samples collected on day 14
and 28 were cryopreserved and later analyzed for neutrophil-
mediated antibody-dependent cellular cytotoxicity (ADCC) and
phagocytosis of S^ aureus , and for concanavalin A (con A) ,
phytohemagglutinin (PHA) , and pokeweed mitogen (PWM) induced
proliferation.
Cryopreservation of cells adversely affected
immunological functions in all assays, however function was
affected predictably in all but PWM stimulated cells of calves
supplemented with vitamin C. The ocular and nasal discharge
scores of calves supplemented with vitamin C and vitamins C
and E were lower than those of control calves for all eight
weeks. Neutrophils of calves supplemented with vitamin C had
phagocytosis and lysis functions decreased from control calf
neutrophil functions at weeks two and four. Neutrophil
function of calves supplemented with vitamins C and E together
was near the level of controls or slightly higher for weeks
two and four, suggesting that the addition of vitamin E with
vitamin C negated the adverse effects that vitamin C alone had
on neutrophil mediated ADCC and phagocytosis. A similar trend,
reduced gain in vitamin C supplemented calves and a slight
increase in gain in vitamin C and E supplemented calves from
controls was seen. Lymphocyte proliferation with all three
mitogens showed a trend for vitamin C and E supplemented
calves to have a higher response at week two but no difference
between treatments at week four.
